ITGAM and neoplasm: Tumor-infiltrating CD11b myeloid cells consisted of two major MDSC subsets, and the CD11b+HLA-DR+ cell subset, which represented about 60–70% of all tumor-infiltrated myeloid cells, was highly heterogeneous, comprising a mixture of MDSCs, TAMs, and immature DCs [99].